SerialStateLineXer t1_j0q2b5e wrote
Reply to comment by DanDierdorf in Cambridge scientists have shown that a widely-used drug to treat liver disease can prevent SARS-CoV-2 infection or reduce COVID-19 severity by hot
See table 12 here. Among people age 18-64 getting a second dose of Moderna, 17% reported a fever (possibly biased downwards by people not taking temperature), over 60% reported headache, fatigue, and myalgia, and nearly 48% reported chills. This is significantly higher than for people over age 65 or for people age 18-64 getting the first dose.
Viewing a single comment thread. View all comments